ASCRS 2023: ViaLase to present clinical data, technology overview

Article

The medical technology company ViaLase will reveal the 2-year data from their FLigHT clinical study as well as give additional information about their pipeline at ASCRS 2023.

Doctor from ViaLase presents data at ASCRS 2023 (Image credit: Adobe Stock/©wellphoto)

(Image credit: Adobe Stock/©wellphoto)

ViaLase announced that they will present clinical data from their first-in-human initial study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) as well as a technology overview at The American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, which will be held May 5-8, 2023 in San Diego, California. The clinical-stage medical tech company is developing a noninvasive image-guided femtosecond laser for the treatment of glaucoma in the hopes of addressing unmet needs in the conventional treatment paradigm.

“We are excited to present our 2-year clinical data to the ophthalmic community and continue to share the potential value of the micron accuracy, non-invasive treatment of glaucoma performed with advanced image-guided, femtosecond laser technology,” Tibor Juhasz, PhD, founder and CEO of ViaLase, said in a press release. “The results mark an important first step in demonstrating FLigHT’s potential as a safe and effective treatment option for patients with primary open angle glaucoma. We are optimistic about the new opportunities ViaLase’s FLigHT treatment can offer to practices and patients alike.”

Presenters for ViaLase include Cathleen M. McCabe, MD; Professor Zoltan Nagy, MD; and Richard A. Lewis, MD.

  • Up and coming glaucoma technologies: Almost ready for prime time
    • Presented by Cathleen M. McCabe, MD
    • Friday, May 5, 2023
    • 4:29-4:38 pm PDT
    • San Diego Convention Center, Upper Level, Room 6B
  • First-in-human study of femtosecond laser image-guided high-precision trabeculotomy (FLigHT) for glaucoma treatment: 2-Year outcomes
    • Presented by Professor Zoltan Nagy, MD
    • Saturday, May 6, 2023
    • 2:47-2:52 pm PDT
    • San Diego Convention Center, Upper Level, Room 5B
  • ASCRS innovator’s session – Angle imaging: The unmet need in MIGS
    • Presented by Richard A. Lewis, MD
    • Monday, May 8, 2023
    • 8:00-9:30 am PDT
    • San Diego Convention Center

Thomas W. Samuelson, MD, will also present a Marketplace Company Showcase as a part of Eyecelerator, a popular pipeline review and technology spotlight that often accompanies major meetings. Eyecelerator will take place on Thursday, May 4, 2023 from 1:00-2:30 pm PDT.

Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
What was the biggest innovation in eye care in 2024?
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
© 2024 MJH Life Sciences

All rights reserved.